Venu
Position Trader, Market Leaders, Fundamental/Technical Analysis
Rocket Lab could become a $200B+ company over the next two to three years and remains a top-five conviction holding. It is one of very few stocks worth buying below its 200-day moving average, because the long-term opportunity looks far larger than the short-term technical weakness. The stock is already up 30% over the past week. x.comÂ
Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com x.com x.comÂ
Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.comÂ
Rocket Lab's price bets on the most optimistic version of its results a decade out while it is still losing money, so the market is pricing a story rather than the company. Narrative now earns a premium and earnings do not, as with IonQ and AI-server-labeled Dell and HPE, and one quarterly miss means exit. This can last a long time in liquid, risk-on markets, as 1999 dot-coms and 2021 SPACs showed, so a drop is not imminent; buyers now are buying how long sentiment lasts. x.comÂ
Voyager Technologies looks particularly interesting as a picks-and-shovels supplier to the space economy. At a $1.5B market cap, it builds propulsion, missile defense, spacecraft electronics, space intelligence and agentic AI, stations, lunar infrastructure and orbital computing; it partners with Palantir and Anduril. Rocket Lab, AST SpaceMobile and Voyager could be like Apple, Microsoft and Intel in the 1980s: their value in two decades matters more than in two years. x.comÂ
Rocket Lab is underestimated as a launch company when it is building a broader space infrastructure business, where satellites, components, spacecraft systems and national-security demand could matter as much as launches. It just signed its largest commercial Electron deal by mission count, 20 launches for Synspective from 2028 to 2031, per Wall St Engine, pushing its launch backlog above 100 missions. x.comÂ
Rocket Lab could face a difficult 9-12 months because much of the space industry's future is already priced into equity valuations, even as its business and backlog grow. A monthly close below the $61 21-month EMA would raise the risk that the uptrend has ended and shift attention toward $35-45 for a better long-term entry; holding $61 preserves a more constructive reading. The company could still trade considerably higher over a longer horizon. x.comÂ
Rocket Lab remains a long-term bet on the strength of the space sector and growing demand for launch platforms, even though it is expected to stay GAAP-unprofitable until around 2028. Goldman Sachs estimates SpaceX could reach $474 billion of revenue by 2030, including $322 billion from AI, showing how large the commercial space opportunity could become. Rocket Lab's largest commercial Electron contract, 20 Synspective launches for 2028-2031, lifted its backlog above 100 missions. x.comÂ
Good SpaceX earnings could help Rocket Lab lead the new-space sector higher with a rally as violent as its capitulation. Rocket Lab is the sector leader outside SpaceX; its RSI is extremely oversold, the lower Bollinger band is overstretched and MACD's negative divergence is subsiding. Three upside gaps lie at $55.25-59.18, $64.22-65.71 and $73.11-74.76. The highest should fill before year-end, though the exact date is hard to predict. x.com x.comÂ
Rocket Lab's $3B at-the-market offering shows it needs investor cash because it has no real earnings or path to profitability, and it should have raised $10-15B while the window lasts. Selling stock at such a high valuation is the only way to sustain the next 18-24 months, and the coming SpaceX IPO will most likely be the sell event for the entire space sector. x.com x.comÂ
Rocket Lab's after-hours selloff on a record quarter is a buying opportunity because it is becoming a space prime, one of only two full-stack space companies alongside SpaceX. Revenue hit a record $234M, up 62%, backlog a record $2.36B, up 137%, with more than $1B of Q3 contracts signed and $2.4B of cash. On VICTUS HAZE it launched in 16h42m against a 24-hour window. CEO Peter Beck said Neutron delay coverage is exaggerated. Rating stays Overweight with a $130 target. x.com x.com x.comÂ
